Abstract
Nrf2 (NFE2L2) is a transcription factor belonging to the Cap‘N’Collar subfamily of basic-leucine zipper (bZIP) family of transcription factors, which plays a significant role in adaptive responses to oxidative stress. To investigate the relationship of between the mutation of Nrf2 gene and non-small cell lung cancer (NSCLC), in this study, we sequenced the Nrf2 gene from a total of 103 patients with NSCLC and corresponding blood samples. It is found that there is a discordance of Nrf2 mutations between NSCLC and corresponding blood samples. These differences may indicate that the variants in the Nrf2 gene are associated with an increased risk for lung cancer. In addition, the factor of smoking status is observed to play important roles in triggering the occurrence of the disorder.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Parkin DM et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
Pao W, Girard N (2010) New driver mutations in non-small-cell lung cancer. Lancet Oncol 12(2):175–180
Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359(13):1367–1380
Kim YR et al (2010) Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol 220(4):446–451
Kensler TW, Wakabayashi N (2010) Nrf2: friend or foe for chemoprevention? Carcinogenesis 31(1):90–99
Moi P et al (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA 91(21):9926–9930
Kobayashi A et al (2006) Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 26(1):221–229
Shibata T et al (2008) Cancer related mutations in Nrf2 impair its recognition by Keap1–Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 105(36):13568–13573
Hayes JD, McMahon M (2009) Nrf2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 34(4):176–188
Kobayashi S et al (2005) EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352(8):786–792
Montgomery KT et al (2008) PolyPhred analysis software for mutation detection from fluorescence-based sequence data. Curr Protoc Hum Genet 7(7):485–486
Katoh Y et al (2001) Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 6(10):857–868
Sherry ST et al (2001) dbSNP: the NCBI database of genetic variation. Nucl Acids Res 29(1):308–311
Bao L, Zhou M, Cui Y (2005) nsSNPAnalyzer: identifying disease-associated nonsynonymous single nucleotide polymorphisms. Nucl Acids Res 33(Web Server issue):W480–W482
Zhang DD (2006) Mechanistic studies of the Nrf2–Keap1 signaling pathway. Drug Metab Rev 38(4):769–789
Ahrendt SA et al (2001) Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 92(6):1525–1530
Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458(7239):719–724
Acknowledgments
This study is supported by the 11.5 Foundation of Chinese PLA (06G106) and the National Natural Sciences Foundation of China (30672428).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, Y., Ju, Y., Lin, D. et al. Mutation of the Nrf2 gene in non-small cell lung cancer. Mol Biol Rep 39, 4743–4747 (2012). https://doi.org/10.1007/s11033-011-1266-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-011-1266-4